SPOKE LEADER
- National Research Council (CNR)
Affiliated Partners
- University of Florence (UNIFI)
- University of Pisa (UNIPI)
- National Institute of Nuclear Physics (INFN)
Spoke 1 models and experiments with innovative approaches to radiotherapy and oncological diagnostics, such as the revolutionary FLASH Radiotherapy and new theranostic radiopharmaceuticals, with prospects for clinical implementation in the treatment of radioresistant tumors and a reduction in collateral effects and treatment times.
This new challenge has a strongly multidisciplinary nature, involving physicists, doctors, radio-oncologists, chemists, and biologists.
Spoke 1 includes preclinical studies and clinical validation, with impacts on sectors such as photonics, hospital accelerators, dosimetry, and treatment planning software.
Interview with:
Leonida Gizzi, spoke leader of Spoke 1.
Interviews with:
Simona Piccinini, National Institute of Optics of the National Research Council, Ambassador THE.
Gabriele Bandini, National Institute of Optics of the National Research Council.
